546 — Fufeng Balance Sheet
0.000.00%
- HK$19.81bn
- HK$22.05bn
- CNY27.76bn
Annual balance sheet for Fufeng, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,052 | 7,008 | 6,856 | 10,648 | 13,466 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,095 | 1,813 | 2,393 | 2,273 | 1,928 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11,201 | 15,852 | 19,715 | 22,532 | 28,306 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10,080 | 10,288 | 12,687 | 13,423 | 14,751 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 21,511 | 26,389 | 32,561 | 36,090 | 43,715 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,374 | 9,388 | 14,045 | 16,240 | 22,847 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8,833 | 10,895 | 15,237 | 17,747 | 24,255 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 12,678 | 15,494 | 17,324 | 18,343 | 19,460 |
| Total Liabilities & Shareholders' Equity | 21,511 | 26,389 | 32,561 | 36,090 | 43,715 |
| Total Common Shares Outstanding |